SNCA and Parkinson disease: These data support the notion that exogenous CoQ10 supplementation can suppress lipid peroxidation, protect dopaminergic neurons, and inhibit α-synuclein aggregation in PD models (281), highlighting the therapeutic potential of CoQ10-based interventions.